Using our AI model trained on historical data, we generated a 12‑month forecast for Regeneron Pharmaceuticals Inc. (REGN) stock. The model estimates a median target price of 971.13—ranging from a low of 859.39 to a high of 1085.07—which suggests an increase of 41.72% compared to the current price of 685.26.